respiratory

News

Roche aims to extend shelf life of Xolair with new prefilled...

The FDA has approved a new prefilled syringe formulation for Roche’s asthma drug Xolair, as the Swiss company aims to prolong its shelf life.

News

CSL Behring lung drug would cost NHS £8m per patient, says N...

NICE has rejected CSL Behring’s alpha1-proteinase inhibitor Respreeza for treating genetic emphysema in draft guidance, saying that it would cost a massive £8 million to give a patient a ye

News

AZ COPD drug fails to match GSK rival after disappointing la...

AstraZeneca has said it is analysing “inconsistent” results after a late-stage trial of its Bevespi Aerosphere inhaler in chronic obstructive pulmonary disease (COPD) failed to match the pe

News

GSK's Nucala unlikely to get COPD use after panel vote

FDA due to make decision in September

News

AZ suffers setback as NICE slaps restrictions on Fasenra

Fasenra can only be used after GSK rival, NICE says in draft decision

News

NICE restricts use of antibiotics in draft COPD guidance

NICE has published draft guidance restricting use of antibiotics in patients with chronic obstructive pulmonary disease (COPD), as in many cases the treatment is inappropriate and could lea

Roche aims to extend shelf life of Xolair with new prefilled...

CSL Behring lung drug would cost NHS £8m per patient, says N...

AZ COPD drug fails to match GSK rival after disappointing la...

GSK's Nucala unlikely to get COPD use after panel vote

AZ suffers setback as NICE slaps restrictions on Fasenra

NICE restricts use of antibiotics in draft COPD guidance

Repligen builds in cell therapy with $1.5bn BioLife takeover

Discover a new era of healthcare panel engagement: Grounded ...

respiratory

Editor's Picks